24/120
1.0 / 5 stars
All 120 Win/Lose results shown below
LGNDZ Roast Me summary
LIGAND PHARMACEUTICALS INC (LGNDZ). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 15.20% |
WinLGNDZ / S&P 54.89% / 15.00% |
LoseLGNDZ / S&P LGNDZ unavailable / 50.40% |
| 2026-Q11/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -4.33% |
WinLGNDZ / S&P 51.24% / 11.30% |
LoseLGNDZ / S&P LGNDZ unavailable / 27.70% |
| 2025-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 2.65% |
WinLGNDZ / S&P 60.40% / 9.00% |
LoseLGNDZ / S&P LGNDZ unavailable / 13.40% |
| 2025-Q31/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 8.12% |
WinLGNDZ / S&P 64.83% / 4.61% |
LoseLGNDZ / S&P -19.12% / 13.45% |
| 2025-Q21/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 10.94% |
WinLGNDZ / S&P 40.54% / 4.83% |
LoseLGNDZ / S&P -274.89% / 10.63% |
| 2025-Q11/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -4.27% |
WinLGNDZ / S&P 53.40% / 4.98% |
LoseLGNDZ / S&P -234.59% / 10.57% |
| 2024-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 2.41% |
WinLGNDZ / S&P 27.28% / 5.25% |
LoseLGNDZ / S&P -107.48% / 6.15% |
| 2024-Q31/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 5.89% |
LoseLGNDZ / S&P -0.76% / 5.89% |
WinLGNDZ / S&P 206.10% / 6.11% |
| 2024-Q21/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 4.28% |
LoseLGNDZ / S&P -25.82% / 5.38% |
WinLGNDZ / S&P 61.54% / 5.12% |
| 2024-Q11/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 10.56% |
LoseLGNDZ / S&P -41.92% / 5.71% |
WinLGNDZ / S&P 325.60% / 5.59% |
| 2023-Q40/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 11.69% |
LoseLGNDZ / S&P -33.09% / 6.81% |
LoseLGNDZ / S&P LGNDZ unavailable / 7.78% |
| 2023-Q30/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -3.27% |
LoseLGNDZ / S&P -15.95% / 7.52% |
LoseLGNDZ / S&P LGNDZ unavailable / -5.03% |
| 2023-Q20/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 8.74% |
LoseLGNDZ / S&P -4.47% / 9.50% |
LoseLGNDZ / S&P LGNDZ unavailable / -8.57% |
| 2023-Q11/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 7.50% |
LoseLGNDZ / S&P -8.61% / 10.77% |
WinLGNDZ / S&P -7.41% / -15.69% |
| 2022-Q40/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 7.56% |
LoseLGNDZ / S&P -18.75% / 11.88% |
LoseLGNDZ / S&P -159.82% / -17.99% |
| 2022-Q30/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -4.88% |
LoseLGNDZ / S&P LGNDZ unavailable / 13.47% |
LoseLGNDZ / S&P -131.75% / -1.41% |
| 2022-Q20/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -16.10% |
LoseLGNDZ / S&P LGNDZ unavailable / 13.71% |
LoseLGNDZ / S&P -117.63% / 11.04% |
| 2022-Q10/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -4.60% |
LoseLGNDZ / S&P LGNDZ unavailable / 15.97% |
LoseLGNDZ / S&P -41.56% / 42.23% |
| 2021-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 11.03% |
WinLGNDZ / S&P 47.68% / 15.00% |
LoseLGNDZ / S&P LGNDZ unavailable / 96.40% |
| 2021-Q30/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 0.58% |
LoseLGNDZ / S&P LGNDZ unavailable / 10.77% |
LoseLGNDZ / S&P LGNDZ unavailable / 69.42% |
| 2021-Q20/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 8.55% |
LoseLGNDZ / S&P LGNDZ unavailable / 6.58% |
LoseLGNDZ / S&P LGNDZ unavailable / 51.81% |
| 2021-Q10/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 6.17% |
LoseLGNDZ / S&P LGNDZ unavailable / -1.06% |
LoseLGNDZ / S&P LGNDZ unavailable / 7.39% |
| 2020-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 12.15% |
WinLGNDZ / S&P 35.98% / -3.72% |
LoseLGNDZ / S&P -100.57% / -33.42% |
| 2020-Q30/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 8.93% |
LoseLGNDZ / S&P LGNDZ unavailable / -2.04% |
LoseLGNDZ / S&P -100.00% / -27.10% |
| 2020-Q20/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 20.54% |
LoseLGNDZ / S&P LGNDZ unavailable / -0.46% |
LoseLGNDZ / S&P -101.23% / -27.11% |
| 2020-Q10/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -19.60% |
LoseLGNDZ / S&P LGNDZ unavailable / 3.47% |
LoseLGNDZ / S&P -106.91% / -14.75% |
| 2019-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 9.07% |
LoseLGNDZ / S&P -52.17% / 5.36% |
WinLGNDZ / S&P 434.40% / 2.99% |
| 2019-Q31/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 1.70% |
LoseLGNDZ / S&P LGNDZ unavailable / 5.02% |
WinLGNDZ / S&P 284.68% / 0.21% |
| 2019-Q21/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 4.30% |
LoseLGNDZ / S&P LGNDZ unavailable / 6.64% |
WinLGNDZ / S&P 551.54% / 8.65% |
| 2019-Q11/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 13.65% |
LoseLGNDZ / S&P LGNDZ unavailable / 8.12% |
WinLGNDZ / S&P 1557.01% / 14.29% |
| 2018-Q42/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -13.52% |
WinLGNDZ / S&P 78.21% / 9.05% |
WinLGNDZ / S&P 1024.53% / 18.23% |
| 2018-Q31/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 7.71% |
LoseLGNDZ / S&P LGNDZ unavailable / 10.21% |
WinLGNDZ / S&P 959.42% / 19.06% |
| 2018-Q21/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 3.43% |
LoseLGNDZ / S&P LGNDZ unavailable / 9.03% |
WinLGNDZ / S&P 1181.58% / 14.46% |
| 2018-Q10/3 |
LoseLGNDZ / S&P LGNDZ unavailable / -0.76% |
LoseLGNDZ / S&P LGNDZ unavailable / 7.68% |
LoseLGNDZ / S&P LGNDZ unavailable / 12.46% |
| 2017-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 6.64% |
WinLGNDZ / S&P 29.48% / 7.03% |
LoseLGNDZ / S&P LGNDZ unavailable / 13.82% |
| 2017-Q31/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 4.48% |
LoseLGNDZ / S&P LGNDZ unavailable / 5.68% |
WinLGNDZ / S&P 130.00% / 17.57% |
| 2017-Q20/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 3.09% |
LoseLGNDZ / S&P LGNDZ unavailable / 4.83% |
LoseLGNDZ / S&P -96.01% / 17.74% |
| 2017-Q10/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 6.07% |
LoseLGNDZ / S&P LGNDZ unavailable / 3.67% |
LoseLGNDZ / S&P -101.65% / 13.32% |
| 2016-Q41/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 3.82% |
WinLGNDZ / S&P 51.53% / 2.09% |
LoseLGNDZ / S&P -100.74% / 7.05% |
| 2016-Q30/3 |
LoseLGNDZ / S&P LGNDZ unavailable / 3.85% |
LoseLGNDZ / S&P LGNDZ unavailable / 0.20% |
LoseLGNDZ / S&P -97.21% / -3.15% |
Dividend-reinvested, split-adjusted total return
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.